External Validation and Bayesian Forecasting of Rivaroxaban Population Pharmacokinetic Models in Older Chinese Patients with Nonvalvular Atrial Fibrillation.
- DOI
- 10.2147/dddt.s632231
- Published
- 2026
- Container
- Drug design, development and therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2147/dddt.s632231,
title = {External Validation and Bayesian Forecasting of Rivaroxaban Population Pharmacokinetic Models in Older Chinese Patients with Nonvalvular Atrial Fibrillation.},
author = {Chen J and Huang W and Chen G and Ge B and Zhao Q and Wang H and Ye J and Pan J and Mao K},
year = {2026},
journal = {Drug design, development and therapy},
doi = {10.2147/dddt.s632231},
url = {https://doi.org/10.2147/dddt.s632231}
}RIS
TY - JOUR TI - External Validation and Bayesian Forecasting of Rivaroxaban Population Pharmacokinetic Models in Older Chinese Patients with Nonvalvular Atrial Fibrillation. AU - Chen J AU - Huang W AU - Chen G AU - Ge B AU - Zhao Q AU - Wang H AU - Ye J AU - Pan J AU - Mao K PY - 2026 JO - Drug design, development and therapy DO - 10.2147/dddt.s632231 UR - https://doi.org/10.2147/dddt.s632231 ER -
APA
J, C., W, H., G, C., B, G., Q, Z., H, W., J, Y., J, P., & K, M. (2026). External Validation and Bayesian Forecasting of Rivaroxaban Population Pharmacokinetic Models in Older Chinese Patients with Nonvalvular Atrial Fibrillation.. Drug design, development and therapy. https://doi.org/10.2147/dddt.s632231
Source records
- pubmed · retrieved 2026-09-25T04:30:47.323Z